A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...

A new clinical trial found that taking a popular diabetes and weight-loss drug once weekly significantly improves blood sugar ...

For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide ...

Novo Nordisk has ended its collaboration with Hims & Hers Health for its Wegovy weight-loss blockbuster treatment roughly a month after it began over concerns about what it said was illegal mass ...

Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term ...

Flash forward to today however, and Weight Watchers has filed for bankruptcy while weight loss jabs like Mounjaro, Ozempic, ...

How do weight loss drugs like Ozempic and Mounjaro work? Administered as weekly jabs, these drugs – often called GLP-1 ...

Novo Nordisk has ended its collaboration with Hims & Hers Health for its Wegovy weight-loss blockbuster treatment roughly a month after it began.

With weight-loss injections like Semaglutide gaining popularity, experts warn they’re not a one-size-fits-all fix. We got in touch with an expert who explains why long-term success lies in combining ...